Related Experiment Videos
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians
B Nikpoor1, G Turecki, C Fournier
1Center for Research in Neuroscience, McGill University, and the Montreal General Hospital Research Institute, Montreal, Quebec, Canada.
Background:
One of the enzymes involved in the production of free radicals in atherosclerotic plaques is myeloperoxidase (MPO). There is a functional G/A polymorphism 463 bp upstream of the transcription start site of the enzyme with the G allele associated with a higher level of MPO expression than the A allele. Considering the potential role of MPO in the process of atherosclerosis, studying the relationship between this polymorphism and the incidence of coronary artery disease (CAD) seems reasonable.
Method:
We performed a case-control study. The case group consisted of 229 patients who had angiographically proved atherosclerotic plaques in their coronary arteries. The control group consisted of 217 individuals who did not have a history of coronary artery disease, stroke, or peripheral vascular disease.
Results:
We found that allele A of the MPO gene was less frequent in cases with CAD. In a recessive model patients with the AA genotype had a decreased risk of CAD (odds ratio 0.138, 95% confidence interval 0.040-0.474). In a dominant model a significant protective role for AA or AG versus GG was also detected (odds ratio 0.639, 95% confidence interval 0.436-0.937).
Conclusion:
Our findings suggest that the -463 G/A polymorphism of the MPO gene influences the risk of CAD. This effect may be mediated by the effect of this polymorphism on the transcription level of the MPO gene.
Insights
The myeloperoxidase (MPO) gene's -463 G/A polymorphism appears to influence coronary artery disease (CAD) risk. Individuals with the AA genotype show a reduced risk, suggesting a protective effect of this MPO gene variant.
Area of Science:
- Genetics
- Cardiovascular Disease Research
- Molecular Biology
Background:
- Myeloperoxidase (MPO) is an enzyme implicated in free radical production within atherosclerotic plaques.
- A functional G/A polymorphism (-463 bp upstream of the transcription start site) in the MPO gene exists, with the G allele linked to higher MPO expression than the A allele.
Purpose of the Study:
- To investigate the association between the MPO gene's -463 G/A polymorphism and the incidence of coronary artery disease (CAD).
- To explore the potential role of MPO activity, influenced by genetic variation, in the pathogenesis of atherosclerosis.
Main Methods:
- A case-control study design was employed.
- The study included 229 patients with angiographically confirmed coronary atherosclerotic plaques (cases) and 217 individuals without a history of cardiovascular disease (controls).
Main Results:
- The A allele of the MPO gene was found to be less frequent in patients with CAD.
- A recessive model indicated that individuals with the AA genotype had a significantly decreased risk of CAD (OR 0.138).
- A dominant model also revealed a protective role for the AA or AG genotypes compared to GG (OR 0.639).
Conclusions:
- The -463 G/A polymorphism in the MPO gene appears to modulate the risk of developing CAD.
- This influence on CAD risk is potentially mediated through the polymorphism's impact on MPO gene transcription levels.